March 12, 2024 | Investigation
National investment loss lawyers KlaymanToskes is investigating brokerage firms and financial advisors who unsuitably recommended investments in Bank of Montreal (“BMO”) Barrier Notes (linked to Pinterest or Square) to their customers. Our firm believes many investors may have been misled regarding the risks and underlying volatility associated with BMO’s structured note investment offerings, and other...
Read More
February 28, 2024 | Investigation
Alternative Investments are different from typical stocks and bonds, as they are usually private, as opposed to being publicly-traded. Alternatives, including investments in real estate, hedge funds, and private equity can be complicated, difficult to sell, and not as closely monitored by regulators as traditional investments. They also often have high fees and can be...
Read More
August 14, 2023 | Investigation
National investment fraud lawyers KlaymanToskes continues investigating Clovis Oncology, Inc., a now-bankrupt pharmaceutical company, on behalf of Clovis’s shareholders and unsecured noteholders, who are now owed more than $400 million. After filing for Chapter 11 bankruptcy in December 2022 and having its common stock delisted from the NASDAQ, Clovis Oncology reported a net worth of...
Read More
August 11, 2023 | Investigation
National investment fraud lawyers KlaymanToskes continues investigating Horizon Private Equity III, an alleged decade-long, $110 million Ponzi scheme orchestrated by John J. Woods, who recently pleaded guilty to defrauding hundreds of investors. KlaymanToskes recently reported that the firm has filed a $1,000,000 FINRA arbitration claim (no. 23-02037) on behalf of an elderly couple who were...
Read More
